Loss of MECP2 binding ability to 5mC-DNA

Stable Identifier
R-HSA-9022538
Type
Pathway
Species
Homo sapiens
Compartment
nucleoplasm
ReviewStatus
5/5
Locations in the PathwayBrowser
Expand all
General
SVG | 
PNG
Low
Medium
High
 | PPTX  | SBGN
Loss of MECP2 binding ability to 5mC-DNA
Click the image above or here to open this pathway in the Pathway Browser
Missense mutations in the methyl-CpG binding domain (MBD) of methyl-CpG-binding protein 2 (MECP2), spanning amino acids 90 to 162, negatively affect the binding ability of MECP2 to methylated DNA (Ghosh et al. 2008, Ho et al. 2008, Goffin et al. 2012, Mellen et al. 2012).
Literature References
PubMed ID Title Journal Year
18313390 MeCP2 binding to DNA depends upon hydration at methyl-CpG

Schmiedeberg, L, Ho, KL, Bird, AP, McNae, IW, Klose, RJ, Walkinshaw, MD

Mol. Cell 2008
23260135 MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system

Dewell, S, Heintz, N, Mellén, M, Kriaucionis, S, Ayata, P

Cell 2012
22119903 Rett syndrome mutation MeCP2 T158A disrupts DNA binding, protein stability and ERP responses

Greenberg, ME, Siegel, SJ, Blendy, JA, Carlson, GC, Goffin, D, Ong, C, Hu, L, Cohen, S, Wang, IT, Zhang, L, Mercado-Berton, A, Amorim, M, Reyes, AR, Zhou, Z, Allen, M

Nat. Neurosci. 2011
18499664 Rett syndrome-causing mutations in human MeCP2 result in diverse structural changes that impact folding and DNA interactions

Horowitz-Scherer, RA, Gierasch, LM, Ghosh, RP, Nikitina, T, Woodcock, CL

J. Biol. Chem. 2008
Participants
Events
Participates
as an event of
Disease
Name Identifier Synonyms
Rett syndrome DOID:1206 Rett's disorder, cerebroatrophic hyperammonemia
Authored
Orlic-Milacic, M  (2017-10-02)
Reviewed
Krishnaraj, R  (2018-08-07)
Christodoulou, J  (2018-08-07)
Created
Orlic-Milacic, M  (2017-09-25)
Cite Us!